CS01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CS01, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]